Abstract
The aim of this national, multicenter, cross-sectional study was to assess the prevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV) among prisoners, and to identify related risk behaviors including injection drug use. Overall, 4,894 inmates from 20 prisons were enrolled. To have a comparison group, prison staff were also asked to take part. Altogether, 1,553 of the 4,894 inmates from seven prisons completed a questionnaire on risk behaviors. According to the survey, 1.5%, 4.9%, and 0.04% of the prisoners were tested positive for HBsAg, anti-HCV and anti-HIV, respectively. These prevalence data are among the lowest reported from prisons worldwide, although comparable to the Central European data. The prevalence of HBV, HCV, and HIV in the Hungarian prison staff was low (0.38%, 0.47%, and 0%, respectively). The rate of HCV infection was significantly higher among inmates who have ever injected drugs (22.5%) than among inmates who reported they had never injected drugs (1.1%). This first prevalence study of illegal drug injection-related viral infections among Hungarian prisoners points out that ever injecting drugs is the main reason for HCV infection among inmates. The opportunity to reach drug users infected with HCV for treatment underlines the importance of screening programs for blood-borne viruses in prisons.
Similar content being viewed by others
References
Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129-1133.
Castello G, Scala S, Palmieri G, Curley SA, Izzo F. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol. 2010;134:237-250.
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev. 1996;18:137-148.
Holmberg SD. Molecular epidemiology of health care-associated transmission of hepatitis B and C viruses. Clin Liver Dis. 2010;14:37-48.
Rauch A, Rickenbach M, Weber R, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis. 2005;41:395-402.
Dencs A, Farkas A, Gyugos M, et al. Phylogenetic analysis of a nosocomial transmission of hepatitis B virus at a paediatric haematology ward. Acta Microbiol Immunol Hung. 2011;58:23-29.
EMCDDA (2010) Annual report on the state of the drugs problem in Europe. EMCDDA, Lisbon, November 2010. http://www.emcdda.europa.eu/publications/annual-report/2010. Accessed 3 May 2011.
Sweeting M, De Angelis D, Ades A, Hickman M. Estimating the prevalence of ex-injecting drug use in the population. Stat Methods Med Res. 2009;18:381-395.
Bozsonyi K, Csesztregi T, Dudás M, et al. National Report to the EMCDDA by the Reitox National Focal Point. 2010. http://www.drogfokuszpont.hu/dfp_docs/?id=nr_10_en.pdf. Accessed 3 May 2011.
EuroHIV. HIV/AIDS Surveillance in Europe: Mid-year report 2007. Saint-Maurice, France: Institut de Veille Sanitaire; 2007. No. 76. http://www.ecdc.europa.eu/en/activities/surveillance/hiv/Documents/report_eurohiv_midyear_2007.pdf. Accessed 5 May 2011.
Kolari B, Stajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health. 2010;18:104-109.
Zabransky T, Mravcik V, Korcisova B, Rehak V. Hepatitis C virus infection among injecting drug users in the Czech Republic—prevalence and associated factors. Eur Addict Res. 2006;12:151-160.
Laskus T, Radkowski M, Lupa E, et al. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland. J Hepatol. 1992;15:114-117.
Cserszegi T, Csohán Á, Elekes Zs, et al. National Report to the EMCDDA by the Reitox National Focal Point. 2009. http://www.drogfokuszpont.hu/dfp_docs/?id=nr_09_en.pdf. Accessed 5 May 2011.
Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross-sectional survey. BMJ. 2000;321:78-82.
Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997;26:1359-1366.
Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons—not such a pretty picture. Am J Infect Control. 2007;35:477-480.
Long J, Allwright S, Barry J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross-sectional survey. BMJ. 2001;323:1209-1213.
Horne JA, Clements AJ, Drennan P, Stein K, Cramp ME. Screening for hepatitis C virus in the Dartmoor prison population: an observational study. J Public Health (Oxf). 2004;26:372-375.
Hennessey KA, Kim AA, Griffin V, Collins NT, Weinbaum CM, Sabin K. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health. 2009;86:93-105.
Massad E, Rozman M, Azevedo RS, et al. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission. Eur J Epidemiol. 1999;15:439-445.
Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000;3:121-126.
Babudieri S, Longo B, Sarmati L, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76:311-317.
Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007;135:274-280.
Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010;4:144-149.
Burek V, Horvat J, Butorac K, Mikulic R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010;138:1610-1620.
Staneková D, Ondrejka D, Habeková M, Wimmerová S, Kucerková S. Pilot study of risk behaviour, voluntary HIV counselling and HIV antibody testing from saliva among inmates of prisons in Slovakia. Cent Eur J Public Health. 2001;9:87-90.
Caban J, Dolezal M, Błach A, Wiśniowski Z. Detection of HIV antibodies among prisoners from penitentiary units within the district penal institutions in Cracow. Przegl Epidemiol. 1990;44:155-159.
Khan N, Aswad S, Shidban H, et al. Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J Clin Virol. 2004;30:175-182.
Wiessing L, Klempova D, Taylor C et al (2006) Protocol for the implementation of the EMCDDA key indicator: drug-related infectious diseases (DRID), draft version 6 October 2006, Project CT.04.P1.337 EMCDDA, Lisbon. http://www.emcdda.europa.eu/html.cfm/index65537EN.html. Accessed 5 March 2010.
Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons [Erratum in: Am J Public Health. 2004;94:1847]. Am J Public Health. 2004;94:1218-1223.
Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14:e60-e66.
Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92:1789-1794.
Christensen PB, Krarup HB, Niesters HG, Norder H, Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol. 2000;16:1043-1049.
Adjei AA, Armah HB, Gbagbo F, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: a national multicenter study. BMC Infect Dis. 2008;8:33.
Saiz de la Hoya P, Bedia M, Murcia J, Cebria J, Sanchez-Paya J, Portilla J. Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison. Enferm Infecc Microbiol Clin. 2005;23:53-57.
Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96:974-978.
Adjei AA, Armah HB, Gbagbo F, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol. 2006;55:593-597.
Chiaramonte M, Trivello R, Renzulli G, et al. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond). 1982;89:53-58.
Szomor KN, Dencs A, Garai E, Rusvai E, Berencsi G, Takacs M. Mutation spectra of the surface-protein-coding region of the HBV genome in HBV-vaccinated and non-vaccinated individuals in Hungary. Arch Virol. 2008;153:1885-1892.
Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:25-37.
Kheirandish P, SeyedAlinaghi S, Jahani M, et al. Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. J Urban Health. 2009;86:902-908.
Acknowledgments
This work was supported by Schering-Plough Hungary Ltd. (anti-HCV), the Hungarian Prison Service HQ, the Office of the Chief Medical Officer, and the National Center for Epidemiology (HBsAg and anti-HIV). The authors thank the staff of the Department of Hepatitis Viruses and Molecular Virology for the excellent technical assistance. We are grateful to Prof. Eva Gonczol and Carolyn Otterness for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tresó, B., Barcsay, E., Tarján, A. et al. Prevalence and Correlates of HCV, HVB, and HIV Infection among Prison Inmates and Staff, Hungary. J Urban Health 89, 108–116 (2012). https://doi.org/10.1007/s11524-011-9626-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11524-011-9626-x